Yue Zhao1, Jun-E Liu1, Frances Marcus Lewis2, Zhi-Hong Nie1, Hui Qiu1, Jing Han1, Ya-Li Su3, Shen-Shen Yang1. 1. School of Nursing, Capital Medical University, Beijing, China. 2. School of Nursing, University of Washington, Seattle, WA, USA. 3. Breast center, Breast Cancer Center, Beijing Tiantan Hospital affiliated to Capital Medical University, Beijing, China.
Abstract
OBJECTIVE: We investigated the effects of mindfulness-based cognitive therapy on insomnia (MBCT-I) in breast cancer survivors. METHODS: In total, 136 participants were allocated randomly to a MBCT-I group or a waitlist control (WLC) group. Indicators of insomnia and mindfulness were evaluated using the Insomnia Severity Index, actigraphy and the Five Facet Mindfulness Questionnaire. Data were collected at baseline (T1), post-intervention (T2), 3-month follow-up (T3) and 6-month follow-up (T4) time points. RESULTS:Insomnia severity decreased significantly in the MBCT-I group, compared with the WLC group, at T2, T3 and T4 (all p < .001). We found that 59.6% of the MBCT-I group with moderate and severe insomnia improved to no insomnia and subclinical insomnia at T4 relative to T1, accounting for 7.9% and 55.3%, respectively. Compared with the WLC group, the MBCT-I group improved on actigraphy measures of sleep; they exhibited a pattern of decreased sleep onset latency and waking after sleep onset, as well as increased total sleep time and sleep efficiency. Mindfulness also increased more in the MBCT-I group than in the WLC group at T2, T3 and T4 (all p < .001). CONCLUSIONS:MBCT-I may be an efficacious non-pharmacologic intervention to improve sleep quality in breast cancer survivors.
RCT Entities:
OBJECTIVE: We investigated the effects of mindfulness-based cognitive therapy on insomnia (MBCT-I) in breast cancer survivors. METHODS: In total, 136 participants were allocated randomly to a MBCT-I group or a waitlist control (WLC) group. Indicators of insomnia and mindfulness were evaluated using the Insomnia Severity Index, actigraphy and the Five Facet Mindfulness Questionnaire. Data were collected at baseline (T1), post-intervention (T2), 3-month follow-up (T3) and 6-month follow-up (T4) time points. RESULTS:Insomnia severity decreased significantly in the MBCT-I group, compared with the WLC group, at T2, T3 and T4 (all p < .001). We found that 59.6% of the MBCT-I group with moderate and severe insomnia improved to no insomnia and subclinical insomnia at T4 relative to T1, accounting for 7.9% and 55.3%, respectively. Compared with the WLC group, the MBCT-I group improved on actigraphy measures of sleep; they exhibited a pattern of decreased sleep onset latency and waking after sleep onset, as well as increased total sleep time and sleep efficiency. Mindfulness also increased more in the MBCT-I group than in the WLC group at T2, T3 and T4 (all p < .001). CONCLUSIONS: MBCT-I may be an efficacious non-pharmacologic intervention to improve sleep quality in breast cancer survivors.
Authors: Jiayi Yang; Yan Du; Haoran Shen; Shujie Ren; Zhiyuan Liu; Danni Zheng; Qingqing Shi; Youfa Li; Gao-Xia Wei Journal: Int J Environ Res Public Health Date: 2022-08-18 Impact factor: 4.614
Authors: Mohamad Baydoun; Chelsea Moran; Andrew McLennan; Katherine-Ann L Piedalue; Devesh Oberoi; Linda E Carlson Journal: Patient Prefer Adherence Date: 2021-06-09 Impact factor: 2.711